A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity

被引：100
作者：
Griffith, Darren [1 ]
Morgan, Maria P. [2 ]
Marmion, Celine J. [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Dept Pharmaceut & Med Chem, Ctr Synth & Chem Biol, Dublin 2, Ireland
[2] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland
来源：
CHEMICAL COMMUNICATIONS | 2009年 / 44期
基金：
爱尔兰科学基金会;
关键词：
CRYSTAL-STRUCTURE; HYDROXAMIC ACIDS; HUMAN HDAC8; COMPLEXES; CARBOPLATIN; HYDROLYSIS; CANCER; LIGANDS;
D O I：
10.1039/b916715c
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The successful design and synthesis of a novel multifunctional platinum drug candidate with DNA binding, histone deacetylase inhibitory activity and enhanced selectivity for cancer cells are described.
引用
收藏
页码：6735 / 6737
页数：3
相关论文
共 25 条
  • [1] Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery
    Sundarapandian, Thangapandian
    Shalini, John
    Sugunadevi, Sakkiah
    Woo, Lee Keun
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 29 (03) : 382 - 395
  • [2] Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles
    Abed, Atena
    Derakhshan, Maryam
    Karimi, Merat
    Shirazinia, Matin
    Mahjoubin-Tehran, Maryam
    Homayonfal, Mina
    Hamblin, Michael R.
    Mirzaei, Seyed Abbas
    Soleimanpour, Hamidreza
    Dehghani, Sadegh
    Dehkordi, Farnaz Farzaneh
    Mirzaei, Hamed
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Two novel homo/hetero polynuclear complexes for DNA binding, molecular docking and anti-cancer activity
    Cao, Shuhua
    Tai, Xishi
    Li, Kaoxue
    Zhang, Ailing
    Ma, Pengju
    Sui, Guoqing
    Zhang, Liansong
    Tian, Xiaohui
    Wang, Anlin
    Azam, Mohammad
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1325
  • [4] Novel hybrid conjugates with dual estrogen receptor α degradation and histone deacetylase inhibitory activities for breast cancer therapy
    Zhao, Chenxi
    Tang, Chu
    Li, Changhao
    Ning, Wentao
    Hu, Zhiye
    Xin, Lilan
    Zhou, Hai-Bing
    Huang, Jian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [5] Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles
    Igaz, Nora
    Kovacs, David
    Razga, Zsolt
    Konya, Zoltan
    Boros, Imre M.
    Kiricsi, Monika
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 146 : 670 - 677
  • [6] An Anti-Cancer Drug Candidate OSI-027 and its Analog as Inhibitors of mTOR: Computational Insights Into the Inhibitory Mechanisms
    Rehan, Mohd
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (12) : 4558 - 4567
  • [7] Fast and slow versus strong and weak metal-DNA binding: consequences for anti-cancer activity
    Reedijk, Jan
    METALLOMICS, 2012, 4 (07) : 628 - 632
  • [8] N-Heterocyclic Carbene-Platinum Complexes Featuring an Anthracenyl Moiety: Anti-Cancer Activity and DNA Interaction
    Harlepp, Sebastien
    Chardon, Edith
    Bouche, Mathilde
    Dahm, Georges
    Maaloum, Mounir
    Bellemin-Laponnaz, Stephane
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [9] Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
    Van Kanegan, Michael J.
    Dunn, Denise E.
    Kaltenbach, Linda S.
    Shah, Bijal
    He, Dong Ning
    McCoy, Daniel D.
    Yang, Peiying
    Peng, Jiangnan
    Shen, Li
    Du, Lin
    Cichewicz, Robert H.
    Newman, Robert A.
    Lo, Donald C.
    SCIENTIFIC REPORTS, 2016, 6
  • [10] Enhancing Cell Nucleus Accumulation and DNA Cleavage Activity of Anti-Cancer Drug via Graphene Quantum Dots
    Wang, Chong
    Wu, Congyu
    Zhou, Xuejiao
    Han, Ting
    Xin, Xiaozhen
    Wu, Jiaying
    Zhang, Jingyan
    Guo, Shouwu
    SCIENTIFIC REPORTS, 2013, 3
123